Second opinions in medical oncology.

BMC Palliative Care
Ian OlverRob Sanson-Fisher

Abstract

The current study aimed to further our understanding of second opinions among medical oncology patients by examining the proportion of patients who sought a second opinion about their cancer treatment, and why. The study was conducted between 2013 and 2015 in three medical oncology clinics located in public hospitals in Australia: in metropolitan New South Wales, metropolitan Queensland, and in Tasmania. Those patients who provide written informed consent were asked to complete a brief paper and pencil survey in the clinic containing questions on sociodemographic, disease and treatment characteristics. Approximately 1 month later, participants were mailed a second paper and pencil survey which contained questions about whether they had sought a second opinion and their motivation for doing so. Non-responders were followed up by letter at 3 and 6 weeks. Of 823 patients screened for eligibility, 698 eligible patients, 612 provided consent. Of those who consented, 355 completed both the initial survey and the second survey and were included in the analyses. Of the 57 patients who sought a second opinion, the most frequent reasons given for doing so were the need for reassurance (49.1%) and the need to consider the range of treatme...Continue Reading

References

Apr 17, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W A M MellinkJ M Bensing
Dec 22, 2007·Digestive Diseases·Anthony AxonTheodore Rokkas
Apr 24, 2009·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Mariëlle OuwensRichard Grol
Aug 27, 2009·The Medical Journal of Australia·Martin H N TattersallMichael L Boyer
Oct 6, 2009·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Jennifer PhilipPaul Komesaroff
Nov 5, 2013·The Medical Journal of Australia·Ian N Olver, Jutta J Von Dincklage
Jun 1, 2014·Revue des maladies respiratoires·M ZysmanY Martinet
Mar 12, 2015·Health Services Research·Craig Evan PollackKatherine L Kahn
Aug 1, 2015·Journal of Medical Internet Research·Deanna J AttaiJeffrey Landercasper
Dec 22, 2015·Journal of Cancer Research and Clinical Oncology·Dana RuettersJutta Huebner
Jun 14, 2017·The Oncologist·Marij A HillenEllen M A Smets

❮ Previous
Next ❯

Citations

Mar 22, 2021·Patient Education and Counseling·Vicky LehmannMarij A Hillen
Mar 5, 2021·Current Opinion in Oncology·Ian Olver
Jul 28, 2021·International Journal of Cancer. Journal International Du Cancer·Jennifer Gill, Vinay Prasad

❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Pediatric Hematology and Oncology
Oz MordechaiMyriam Weyl-Ben-Arush
The Journal of Continuing Education in the Health Professions
Anupma WadhwaLorelei Lingard
© 2021 Meta ULC. All rights reserved